Anupree Patel Calls for AI‑Driven Research to Transform Indian Pharma
Speaking at the third edition of the IIMA Healthcare Summit, the state minister highlighted that India’s pharmaceutical sector must transition from being a large‑scale producer of generic medicines and vaccines to a hub of drug discovery and innovation. Patel cited the country’s contribution during the COVID‑19 crisis—supplying vaccines and essential medical products to over 200 nations and administering more than 22 million doses domestically—as proof of capability, but stressed that artificial intelligence can accelerate screening, clinical decision‑making and disease surveillance, thereby unlocking new therapeutic pathways.